<?xml version="1.0" encoding="UTF-8" ?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
<url>
	<loc>https://amyloidose-expertise.net/</loc>
	<lastmod>2020-12-21T13:03:28+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/het-expertisenetwerk/</loc>
	<lastmod>2019-11-12T15:04:30+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/het-expertisenetwerk/het-expertisenetwerk-amyloidose/</loc>
	<lastmod>2023-11-28T13:50:33+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/het-expertisenetwerk/bezoek-het-expertisenetwerk/</loc>
	<lastmod>2021-02-25T11:13:22+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/het-expertisenetwerk/het-team/</loc>
	<lastmod>2019-11-19T15:17:02+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/het-expertisenetwerk/behandelcentra/</loc>
	<lastmod>2021-08-24T15:34:56+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/het-expertisenetwerk/heeft-u-zich-al-geregistreerd-in-het-landelijk-register/</loc>
	<lastmod>2019-04-05T10:11:46+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/het-expertisenetwerk/patientgericht-onderzoek/</loc>
	<lastmod>2020-12-03T12:45:55+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/het-expertisenetwerk/internationale-samenwerking/</loc>
	<lastmod>2022-06-28T12:34:40+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/</loc>
	<lastmod>2019-04-18T09:27:48+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/over-amyloidose/</loc>
	<lastmod>2019-12-17T15:51:49+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/over-amyloidose/typen/</loc>
	<lastmod>2021-02-25T11:34:12+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/over-amyloidose/ziektebeeld-en-verloop/</loc>
	<lastmod>2019-11-30T20:04:04+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/over-amyloidose/symptomen/</loc>
	<lastmod>2021-02-25T11:39:30+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/over-amyloidose/diagnose/</loc>
	<lastmod>2019-11-26T14:50:16+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/zorg-bij-amyloidose/</loc>
	<lastmod>2019-10-15T15:31:34+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/patientenorganisatie/</loc>
	<lastmod>2021-02-25T12:20:41+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/</loc>
	<lastmod>2021-12-07T12:41:15+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/stel-een-vraag/</loc>
	<lastmod>2024-01-23T09:22:46+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/</loc>
	<lastmod>2019-04-18T09:27:54+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/collegiaal-consult-expertisenetwerk/</loc>
	<lastmod>2021-05-20T11:49:56+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/</loc>
	<lastmod>2019-10-15T15:33:34+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/amyloidose-verdiepende-informatie/</loc>
	<lastmod>2019-11-26T15:24:55+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/</loc>
	<lastmod>2019-05-10T14:25:19+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/collegiaal-consult/</loc>
	<lastmod>2024-01-16T18:25:11+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/</loc>
	<lastmod>2019-05-08T11:14:32+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/wat-te-doen-bij-spoed/</loc>
	<lastmod>2021-05-20T12:14:05+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/wat-te-doen-bij-spoed/uw-persoonlijke-sos-kaartje/</loc>
	<lastmod>2019-04-05T17:24:46+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/over-deze-website/</loc>
	<lastmod>2022-01-11T12:06:47+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/voor-de-huisarts-informatie-over-amyloidose-3/</loc>
	<lastmod>2019-11-26T15:21:36+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/zorg-bij-amyloidose/behandeling-4/</loc>
	<lastmod>2021-02-25T14:51:12+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/module-van-kwaliteitsstandaard-al-amyloidose-5/</loc>
	<lastmod>2019-11-21T17:18:29+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/typeren-van-amyloid-20/</loc>
	<lastmod>2025-01-28T10:43:07+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/leidraad-fysiotherapie-21/</loc>
	<lastmod>2025-08-19T11:01:48+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/zorg-bij-amyloidose/medisch-onderzoek-11/</loc>
	<lastmod>2021-02-25T14:23:50+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/zorg-bij-amyloidose/erfelijkheid-10/</loc>
	<lastmod>2019-12-17T15:54:20+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/zorg-bij-amyloidose/diagnose-8/</loc>
	<lastmod>2021-02-25T14:18:58+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/instructie-aspireren-van-onderhuids-buikvet-14/</loc>
	<lastmod>2019-11-26T15:17:43+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/zorg-bij-amyloidose/follow-up-zorg-12/</loc>
	<lastmod>2019-12-17T15:55:38+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/zorg-bij-amyloidose/palliatieve-zorg-13/</loc>
	<lastmod>2019-11-30T20:36:38+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/overzicht-typen-amyloidose-en-nomenclatuur-15/</loc>
	<lastmod>2019-11-26T15:17:16+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/basisaanpak-klinische-evaluatie-bij-verdenking-op-amyloidose-16/</loc>
	<lastmod>2020-01-13T16:04:55+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/schema-systematisch-opsporen-oorzaak-aa-amyloidose-en-tabellen-met-oorzaken-17/</loc>
	<lastmod>2021-02-25T15:23:25+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/richtlijnen-amyloidose-18/</loc>
	<lastmod>2023-04-18T12:06:38+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/zorginstrumenten/voor-de-verpleegkundige-al-amyloidose-en-het-hart-19/</loc>
	<lastmod>2022-02-01T14:10:02+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/welke-vragen-moet-ik-aan-mijn-arts-stellen/</loc>
	<lastmod>2019-12-17T16:43:07+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/hoe-krijg-ik-een-doorverwijzing-naar-het-expertisenetwerk-amyloidose/</loc>
	<lastmod>2019-11-30T20:50:33+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/worden-onderzoeken-altijd-vergoed/</loc>
	<lastmod>2019-11-30T20:54:02+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/kan-ik-bij-het-expertisenetwerk-terecht-voor-een-diagnose/</loc>
	<lastmod>2019-11-30T20:47:30+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/welke-informatie-heb-ik-nodig-als-ik-amyloidose-heb/</loc>
	<lastmod>2019-11-30T20:43:16+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/waar-vind-ik-uitgebreide-informatie-over-amyloidose/</loc>
	<lastmod>2019-12-01T10:21:44+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/wat-kan-het-expertisenetwerk-voor-mij-betekenen/</loc>
	<lastmod>2019-12-17T16:43:37+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/wat-zijn-de-gevolgen-van-amyloidose-voor-het-dagelijks-leven/</loc>
	<lastmod>2019-11-30T20:44:36+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/wat-kan-ik-zelf-doen-als-ik-amyloidose-heb/</loc>
	<lastmod>2019-11-30T20:44:09+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/hoe-weet-ik-of-mijn-behandeling-werkt/</loc>
	<lastmod>2019-11-30T20:45:00+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/wordt-er-wetenschappelijk-onderzoek-gedaan-naar-amyloidos-en-de-behandeling-ervan/</loc>
	<lastmod>2019-11-30T20:55:33+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/hoe-werkt-het-expertisenetwerk-samen-met-mijn-eigen-artsen/</loc>
	<lastmod>2019-12-12T09:53:41+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/wat-kan-het-expertisenetwerk-amyloidose-voor-mij-als-zorgverlener-betekenen/</loc>
	<lastmod>2019-11-05T11:34:54+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/waar-moet-ik-als-huisarts-rekening-mee-houden-bij-de-zorg-voor-een-patient-met-amyloidose/</loc>
	<lastmod>2019-12-01T10:20:43+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/hoe-verwijs-ik-mijn-patient-naar-het-expertisenetwerk-amyloidose/</loc>
	<lastmod>2019-12-17T16:44:44+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/waarom-moet-ik-mijn-patient-verwijzen-naar-het-expertisecentrum-amyloidose/</loc>
	<lastmod>2019-12-12T09:45:11+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/bij-welke-klachten-moet-ik-denken-aan-de-mogelijkheid-van-amyloidose/</loc>
	<lastmod>2019-11-05T09:47:45+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/hoe-kan-ik-een-collegiaal-consult-aanvragen-bij-het-expertisenetwerk-amyloidose/</loc>
	<lastmod>2019-12-17T16:45:19+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/welke-patienten-met-amyloidose-komen-in-aanmerking-voor-een-registratie/</loc>
	<lastmod>2019-12-01T10:20:22+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/zijn-er-mogelijkheden-voor-patienten-om-mee-te-doen-aan-wetenschappelijk-onderzoek/</loc>
	<lastmod>2019-12-05T13:16:41+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/met-wie-krijg-ik-te-maken-in-het-expertisenetwerk/</loc>
	<lastmod>2019-12-12T09:51:54+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/is-de-zorg-in-het-expertisenetwerk-beter-dan-in-een-ander-ziekenhuis/</loc>
	<lastmod>2019-12-17T16:44:20+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/hoe-ziet-een-bezoek-aan-het-expertisenetwerk-eruit/</loc>
	<lastmod>2019-11-30T20:52:04+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/bij-welke-locatie-kan-ik-terecht/</loc>
	<lastmod>2019-12-12T09:47:34+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/waarom-vindt-aanvullend-onderzoek-plaats-nadat-de-diagnose-amyloidose-is-gesteld/</loc>
	<lastmod>2019-11-30T20:53:34+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/wat-is-het-verschil-tussen-een-behandelcentrum-en-een-expertisecentrum/</loc>
	<lastmod>2019-12-12T09:59:06+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/hoe-kan-ik-het-expertisenetwerk-bereiken/</loc>
	<lastmod>2019-12-17T16:46:00+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/wat-moet-ik-doen-in-geval-van-een-spoedsituatie/</loc>
	<lastmod>2020-01-27T10:58:39+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/welk-nut-heeft-de-onderhuidse-buikvetpunctie-bij-het-vaststellen-van-het-type-amyloidose/</loc>
	<lastmod>2019-12-12T10:01:51+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/wat-is-een-sap-scan-en-welk-nut-heeft-de-patient-hiervan-bij-de-behandeling/</loc>
	<lastmod>2019-12-12T10:04:35+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/wat-is-een-mibg-scan-en-welk-nut-heeft-de-patient-hiervan-bij-de-behandeling/</loc>
	<lastmod>2019-12-12T10:07:24+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/wat-is-een-mri-en-wat-is-het-nut-hiervan-voor-de-patient/</loc>
	<lastmod>2019-12-17T15:25:07+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/wat-heeft-een-botscan-met-amyloid-in-het-hart-te-maken-en-wat-is-het-nut-hiervan-voor-de-patient/</loc>
	<lastmod>2019-12-17T15:31:20+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/wat-zijn-de-isa-aanbevelingen-tijdens-de-sars-cov2-pandemie/</loc>
	<lastmod>2020-05-07T10:11:16+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-patienten/veelgestelde-vragen-patienten/is-er-informatie-over-vaccinatie-tegen-het-coronavirus-voor-patienten-met-amyloidose/</loc>
	<lastmod>2021-02-15T13:40:36+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/is-er-informatie-over-vaccinatie-tegen-het-coronavirus-voor-patienten-met-amyloidose-zorgverlener/</loc>
	<lastmod>2021-02-15T13:43:54+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/voor-zorgverleners/veelgestelde-vragen-zorgverleners/international-society-of-amyloidosis-recommendations-on-the-management-of-patients-with-systemic-amyloidosis-during-the-covid-19-pandemic/</loc>
	<lastmod>2021-02-18T11:24:31+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/attr-act-studie-behandeling-met-tafamidis-van-patienten-met-attr-amyloid-cardiomyopathie/</loc>
	<lastmod>2021-01-27T09:52:13+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/apollo-studie-patisiran-een-behandeling-met-small-interfering-rna-sirna-voor-erfelijke-attr-amyloidose/</loc>
	<lastmod>2021-01-27T09:54:14+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/emn23-een-retrospectieve-studie-naar-behandeling-en-resultaten-ervan-bij-al-amyloidose-in-europa/</loc>
	<lastmod>2021-01-27T09:47:04+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/hovon-104-studie-bortezomib-gevolgd-door-stamceltransplantatie-bij-al-amyloidose/</loc>
	<lastmod>2021-01-07T10:33:43+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/helios-b-studie-bij-attr-amyloidose/</loc>
	<lastmod>2023-04-25T14:28:04+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/attribute-cm-ag10-bij-attr-amyloidose-en-cardiomyopathie/</loc>
	<lastmod>2023-04-25T14:31:36+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/thaos-een-mondiaal-register-voor-patienten-met-erfelijke-of-wild-type-attr-amyloidose/</loc>
	<lastmod>2021-01-07T09:55:27+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/het-europese-register-voor-autoinflammatoire-ziekten-eurofever/</loc>
	<lastmod>2020-01-27T10:17:14+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/attr-act-extensiestudie-tafamidis/</loc>
	<lastmod>2023-04-25T14:40:09+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/helios-a-vutrisiran-bij-erfelijke-attr-amyloidose-en-polyneuropathie/</loc>
	<lastmod>2023-04-25T14:42:28+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/attribute-cm-extensiestudie-ag10-304/</loc>
	<lastmod>2023-04-25T14:52:49+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/neurimmune-studie-bij-attr-amyloidose/</loc>
	<lastmod>2024-01-17T09:14:36+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/retrospectieve-analyse-gegevens-van-al-amyloidose-patienten-uit-het-umcu-en-umcg-tussen-2008-en-2016/</loc>
	<lastmod>2022-02-22T15:03:01+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/andromeda-studie-gerandomiseerde-fase-iii-studie-eerstelijns-behandeling-al-amyloidose-patienten-cybord-daratumumab-sc/</loc>
	<lastmod>2021-01-27T10:07:47+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/emn22-fase-ii-studie-met-daratumumab-monotherapie-in-nog-onbehandelde-patienten-met-cardiaal-stadium-3b-al-amyloidose/</loc>
	<lastmod>2021-01-27T11:18:12+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/i-care-studie-bij-attr-amyloidose/</loc>
	<lastmod>2025-01-28T10:19:40+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/nederlandse-kanker-registratie-voor-systemische-al-amyloidose/</loc>
	<lastmod>2022-02-22T15:00:32+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/emn27-een-fase-ii-studie-met-belantamab-mafodotin-in-patienten-met-recidief-of-refractair-al-amyloidose/</loc>
	<lastmod>2021-01-27T10:37:57+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://amyloidose-expertise.net/research/apollo-b-studie/</loc>
	<lastmod>2023-04-25T15:01:15+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
</urlset>